Home » Topics » Regulatory » Patents

Patents
RSS

Newly identified human natural killer cell-activating factor reported by HGS

Feb. 3, 1998

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

BASF presents new ET antagonists

Feb. 3, 1998

New analgesic agents from Gruenenthal

Feb. 3, 1998

Heterocyclic bradykinin antagonists in development at Hoechst Marion Roussel

Feb. 3, 1998

Synthelabo claims mixed and specific dopamine receptor ligands

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

AMPA receptor antagonists disclosed by Pfizer

Feb. 2, 1998

New anticonvulsants under study at Bristol-Myers Squibb

Feb. 2, 1998

2,4-Diaminopyrimidines claimed as imaging agents, potentially useful in psychotic disorders

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....